About San Francisco General Hospital - Infectious Diseases
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at San Francisco General Hospital - Infectious Diseases
During the past decade, San Francisco General Hospital - Infectious Diseases conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
2006-12-13
2011-12-15
Completed
46
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
2007-01-24
2018-09-04
Completed
64
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
2009-04-15
2013-03-17
Completed
637
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
2009-11-01
2014-11-01
Completed
242
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
2009-09-01
2025-10-01
Active, not recruiting
1,538
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at San Francisco General Hospital - Infectious Diseases
According to Clinical.Site data, the most researched conditions in "San Francisco General Hospital - Infectious Diseases" are
"Bacterial Vaginosis" (1 trials) and "Staphylococcal Infection" (1 trials). Many other conditions were trialed in "San Francisco General Hospital - Infectious Diseases" in a lesser frequency.
Clinical Trials Intervention Types at San Francisco General Hospital - Infectious Diseases
Most popular intervention types in "San Francisco General Hospital - Infectious Diseases" are "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Clindamycin" (1 trials), "Lactobacillus crispatus CTV-05" (1 trials), "Metronidazole" (1 trials) and "Trimethoprim-sulfamethoxazole" (1 trials). Other intervention names were less common.
Clinical Trials Genders at San Francisco General Hospital - Infectious Diseases
The vast majority of trials in "San Francisco General Hospital - Infectious Diseases" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at San Francisco General Hospital - Infectious Diseases
Currently, there are NaN active trials in "San Francisco General Hospital - Infectious Diseases".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in San Francisco General Hospital - Infectious Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in San Francisco General Hospital - Infectious Diseases, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".